The world's most important university research reactor for fighting cancer.
We'll Show You How.
MURR By The Numbers
500,000
cancer patients were treated last year with radioisotopes produced at MURR.
95%
of thyroid cancer patients are cured after using radioisotopes. Liver, prostate and pancreatic cancer patients have a better quality of life and live longer with radioisotope treatment.
59 years
of safe, innovative history. Operating 24 hours a day, 6.5 days a week, 52 weeks a year — MURR is the most powerful university research reactor in the U.S., working at 10 megawatts.
Tiny atoms, big impact
A Vital Resource
MURR offers a wide range of nuclear products and services to a global community, including custom and off-the-shelf products, research and medical grade isotopes and radiochemicals, and analytical and neutron irradiation services.
Saving and improving lives
Watch Nicole’s story"When we found out that the TheraSphere procedure worked, that was one of the happiest days of my life. TheraSphere saved my life."
Research Across Disciplines
From investigating ancient cultures to analyzing industrial materials and developing radiopharmaceuticals that have lifesaving clinical applications, MURR is a reliable resource for researchers, scientists, engineers and students across the country.
Radioisotope Science Center
The Radioisotope Science Center, operated by the University of Missouri Research Reactor, will advance research, development, production, processing and distribution of nationally strategic radioisotopes in limited supply.
Latest News
March 18, 2026
NextGen MURR teams with Burns & McDonnell, supporting the future of lifesaving nuclear medical isotope production
The drive to build a new state-of-the-art research reactor at Mizzou continues as a major milestone is reached.
March 9, 2026
MURR makes NCA Lu-177 available worldwide
Expanded supply will enable researchers and industry to purchase GMP no-carrier-added Lutetium-177 directly from the reactor.
Feb. 9, 2026
University of Missouri conducts first in-person clinical trial for nuclear medicine breakthrough device
The clinical trial marks the latest human trial at Mizzou involving radioisotopes to treat cancer.
Join the team. Change the world.
The University of Missouri Research Reactor is a great place to work and we are hiring!